Intercure Ltd., a company listed on the Nasdaq Global Market and the Tel Aviv Stock Exchange under the symbols INCR and INCRF, operates in the pharmaceutical industry, specifically as a leading producer and distributor of pharmaceutical-grade cannabis and cannabis-based products for medical use. Established in 1994, Intercure has been at the forefront of the cannabis industry for over 16 years. Intercure's main business activities involve the production, manufacturing, exporting, and distribution of pharmaceutical-grade cannabis and cannabis-based...
No data available.
No data available.
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | ZTS | Zoetis Inc. | 56.15 Bn | 21.18 | 5.98 | 7.27 Bn |
| 2 | TAK | Takeda Pharmaceutical Co Ltd | 48.92 Bn | 221.13 | 1.66 | 36.24 Bn |
| 3 | HLN | Haleon plc | 46.13 Bn | 25.59 | 3.29 | - |
| 4 | TEVA | Teva Pharmaceutical Industries Ltd | 35.27 Bn | 49.54 | 2.10 | 17.07 Bn |
| 5 | UTHR | UNITED THERAPEUTICS Corp | 21.76 Bn | 17.11 | 6.95 | 0.00 Bn |
| 6 | VTRS | Viatris Inc | 14.87 Bn | -4.03 | 1.05 | 14.44 Bn |
| 7 | NBIX | Neurocrine Biosciences Inc | 14.08 Bn | 32.91 | 5.25 | 0.43 Bn |
| 8 | ELAN | Elanco Animal Health Inc | 11.64 Bn | 323.29 | 2.54 | 4.32 Bn |
| Current Valuation | Value | Ind Avg | Percentile |
|---|---|---|---|
| EV to Assets EV to Assets | 0.02 | 24.98 | |
| EV to Cash from Ops. EV/CFO | -0.19 | -85.40 | |
| EV to Debt EV to Debt | 0.07 | 265.88 | |
| EV to EBIT EV/EBIT | -0.33 | -32.65 | |
| EV to EBITDA EV/EBITDA | -0.16 | -29.50 | |
| EV to Free Cash Flow [EV/FCF] EV/FCF | -0.18 | -32.62 | |
| EV to Market Cap EV to Market Cap | 0.08 | -10.98 | |
| EV to Revenue EV/Rev | 0.05 | -700.14 | |
| Price to Book Value [P/B] P/B | 0.33 | 27.22 | |
| Price to Earnings [P/E] P/E | -2.00 | -122.96 |
| Dividend Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Dividend Coverage Ratio Dividend Coverage Ratio | 0.00 | 0.34 | |
| Dividend Payout Ratio % Div Payout % (Qtr) | 0.00 | 4.81 | |
| Dividend per Basic Share Div per Share (Qtr) | 0.00 | 0.07 | |
| FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) | 0.00 | 4.08 | |
| Interest Coverage Int. cover (Qtr) | -1.85 | -38.10 |
| Growth Metrics | Value | Ind Avg | Percentile |
|---|---|---|---|
| Capex Growth (1y) % Capex 1y % (Qtr) | 0.00 | -157.22 | |
| Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) | 187.69 | 44,776.25 | |
| Dividend Growth (1y) % Dividend Growth (1y) % | 0.00 | 2.81 | |
| EBIAT Growth (1y) % EBIAT 1y % (Qtr) | -5.22 | 24.45 | |
| EBITDA Growth (1y) % EBITDA 1y % (Qtr) | 0.00 | 18.14 | |
| EBIT Growth (1y) % EBIT 1y % (Qtr) | 19.79 | 37.66 | |
| EBT Growth (1y) % EBT 1y % (Qtr) | 8.10 | 108.18 | |
| EPS Growth (1y) % EPS 1y % (Qtr) | -19.28 | 52.88 | |
| FCF Growth (1y) % FCF 1y % (Qtr) | 0.00 | -54.47 | |
| Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) | -60.60 | 25.28 |
| Liquidity Ratios | Value | Ind Avg | Percentile |
|---|---|---|---|
| Asset Utilization Ratio Asset Util Ratio (Qtr) | 0.10 | 0.50 | |
| Cash Payout Ratio Cash Payout Ratio | 0.00 | 0.02 | |
| Cash Ratio Cash Ratio (Qtr) | 0.27 | 2.10 | |
| Current Ratio Curr Ratio (Qtr) | 1.85 | 3.92 | |
| Debt to Equity Ratio Debt/Equity (Qtr) | 0.42 | -1.11 | |
| Interest Cover Ratio Int Coverage (Qtr) | -1.85 | -38.10 | |
| Times Interest Earned Times Interest Earned (Qtr) | -1.85 | -38.10 |
| Profitability | Value | Ind Avg | Percentile |
|---|---|---|---|
| EBITDA Margin % EBITDA Margin % (Qtr) | 0.00 | -62,432.09 | |
| EBIT Margin % EBIT Margin % (Qtr) | -49.14 | -63,260.88 | |
| EBT Margin % EBT Margin % (Qtr) | -22.39 | -66,726.96 | |
| Gross Margin % Gross Margin % (Qtr) | 11.40 | 8,332.72 | |
| Net Profit Margin % Net Margin % (Qtr) | -29.20 | -66,728.37 |